Skip to main content
SpringerLink
Log in

Pons herniation into skull base after cabergoline therapy of giant prolactinoma

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Introduction

Pons herniation after cabergoline therapy for giant prolactinoma is a complication not documented in literature.

Case report

We report a medium aged patient who developed secondary hemiparesis after 18 months of medical treatment. MRI revealed pons herniation into the clivus. There was improvement with conservative treatment. Secuencial MRIs are presented showing the tumor at the moment of the diagnosis, tumor shrinkage and pons herniation.

Discussion

Some studies have shown that a significant and rapid tumor shrinkage resulting from treatment with cabergoline can occur and it is thought that some complications are related with this tumor regression, as in the presented case.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ciccarelli A, Daly AF, Bekers A (2005) The epidemiology of prolactinomas. Pituitary 8:3–6

    Article  PubMed  Google Scholar 

  2. Shrivastava RK, Arginteanu MS, King WA et al (2002) Giant prolactinomas: clinical management and long-term follow up. J Neurosurg 97:299–306

    Article  PubMed  Google Scholar 

  3. Delgrange E, Trouillas J, Maiter D et al (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102–2107

    CAS  PubMed  Google Scholar 

  4. Moraes AB, Santos Silta CM, Vieira Neto L, Gadelha MR (2013) Giant prolactinomas: the therapeutic approach. Clin Endocrinol (Oxf) 79:447–456

    Article  CAS  Google Scholar 

  5. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:273–288

    Article  CAS  PubMed  Google Scholar 

  6. Shimon I, Benbassat C, Hadani M (2007) Effectiveness if long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur J Endocrinol 156:225–231

    Article  CAS  PubMed  Google Scholar 

  7. Ivan G, Szigeti-Csucs N, Olah M, Nagy GM, Goth MI (2005) Treatment of pituitary tumors: dopamine agonists. Endocrine 28:101–110

    Article  CAS  PubMed  Google Scholar 

  8. Leong KS, Foy PM, Swift AC et al (2000) CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clin Endocrinol (Oxf) 52:43–49

    Article  CAS  Google Scholar 

  9. Jones SE, James RA, Hall K, Kendall-Taylor P (2000) Optic chiasmal herniation- an under recognized complication of dopamine agonist therapy for macroprolactinoma. Clin Endocrinol (Oxf) 53:529–534

    Article  CAS  Google Scholar 

  10. Raverot G, Jacob M, Jouanneau E, Delemer B, Vighetto A, Pugeat M, Borson-Chazot F (2009) Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma. Clin Endocrinol (Oxf) 70:588–592

    Article  CAS  Google Scholar 

  11. Corsello SM, Ubertini G, Altomare M et al (2003) Giant prolactinomas in men: efficacy of cabergoline treatment. Clin Endocrinol (Oxf) 58:662–670

    Article  CAS  Google Scholar 

  12. Cho EH, Lee SA, Chung JY et al (2009) Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma. J Korean Med Sci 24:874–878

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Dhanwal DK, Sharma AK (2011) Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma. Pituitary 14:384–387

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors report no conflict of interest concerning this paper.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Miguel Servet University Hospital, 1-3 Isabel la Católica Av., 50009, Zaragoza, Spain

    Jesús Moles Herbera, David Rivero Celada, David Fustero de Miguel & Carlos Fuentes Uliaque

  2. Department of Neuroradiology, Miguel Servet University Hospital, Zaragoza, Spain

    Inmaculada Montejo Gañan & Ana Carmen Vela Marín

Authors
  1. Jesús Moles Herbera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Rivero Celada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Inmaculada Montejo Gañan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Fustero de Miguel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carlos Fuentes Uliaque
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ana Carmen Vela Marín
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jesús Moles Herbera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moles Herbera, J., Rivero Celada, D., Montejo Gañan, I. et al. Pons herniation into skull base after cabergoline therapy of giant prolactinoma. Pituitary 18, 68–71 (2015). https://doi.org/10.1007/s11102-014-0558-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-014-0558-9

Keywords

Search

Navigation